The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Open accessAbstract
The precise roles of B cells in promoting the pathogenesis of type 1 diabetes remain undefined. Here, we demonstrate that B cell depletion in mice can prevent or delay diabetes, reverse diabetes after frank hyperglycemia, and lead to the development of cells that suppress disease. To determine the efficacy and potential mechanism of therapeutic B cell depletion, we generated a transgenic NOD mouse expressing human CD20 (hCD20) on B cells. A single cycle of treatment with an antibody specific for hCD20 temporarily depleted B cells and significantly delayed and/or reduced the onset of diabetes. Furthermore, disease established to the point of clinical hyperglycemia could be reversed in over one-third of diabetic mice. Why B cell depletion is therapeutic for a variety of autoimmune diseases is unclear, although effects on antibodies, cytokines, and antigen presentation to T cells are thought to be important. In B cell-depleted NOD mice, we identified what we believe is a novel mechanism by which B cell depletion may lead to long-term remission through expansion of Tregs and regulatory B cells. Our results demonstrate clinical efficacy even in established disease and identify mechanisms for therapeutic action that will guide design and evaluation of parallel studies in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
β-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H., & Shultz, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2049 · Cited by 583
Mizoguchi, A., & Bhan, A. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.705 · Cited by 582
From T to B and back again: positive feedback in systemic autoimmune disease
Shlomchik, M. J., Craft, J. E., & Mamula, M. J. (2001) · Nature Reviews Immunology · doi:10.1038/35100573 · Cited by 572
Self-citationNovel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R., & Mauri, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7868 · Cited by 570
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Yu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 369
Anolik, J. H., Barnard, J., Owen, T., Zheng, B., Kemshetti, S., Looney, R. J., & Sanz, I. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22810 · Cited by 333
Mann, M. K., Maresz, K., Shriver, L. P., Tan, Y., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3447 · Cited by 316
B-Cells Are Required for the Initiation of Insulitis and Sialitis in Nonobese Diabetic Mice
Noorchashm, H., Noorchashm, N., Kern, J., Rostami, S. Y., Barker, C. F., & Naji, A. (1997) · Diabetes · doi:10.2337/diab.46.6.941 · Cited by 266
Solimena, M., Dirkx, R., Hermel, J. M., Pleasic-Williams, S., Shapiro, J. A., Caron, L., & Rabin, D. U. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00564.x · Cited by 259
Falcone, M., Lee, J., Patstone, G., Yeung, B., & Sarvetnick, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1163 · Cited by 254
The mechanisms of action of rituximab in the elimination of tumor cells
Johnson, P., & Glennie, M. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50025 · Cited by 247
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
Ahuja, A., Shupe, J., Dunn, R., Kashgarian, M., Kehry, M. R., & Shlomchik, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3351 · Cited by 239
Self-citationHamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., & Tedder, T. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052283 · Cited by 237
Pathogenic Roles of B Cells in Human Autoimmunity
Martin, F., & Chan, A. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00112-8 · Cited by 224
Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune Diseases
Rastetter, W., Molina, A., & White, C. A. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104249 · Cited by 213
Hamaguchi, Y., Uchida, J., Cain, D. W., Venturi, G. M., Poe, J. C., Haas, K. M., & Tedder, T. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4389 · Cited by 212
Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse
Wong, F. S., Wen, L., Tang, M., Ramanathan, M., Visintin, I., Daugherty, J., Hannum, L. G., Janeway, C. A., & Shlomchik, M. J. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2581 · Cited by 205
Self-citationElimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
Greeley, S. A. W., Katsumata, M., Yu, L., Eisenbarth, G. S., Moore, D. J., Goodarzi, H., Barker, C. F., Naji, A., & Noorchashm, H. (2002) · Nature Medicine · doi:10.1038/nm0402-399 · Cited by 198
Akashi, T. (1997) · International Immunology · doi:10.1093/intimm/9.8.1159 · Cited by 177
Sherry, N. A., Chen, W., Kushner, J. A., Glandt, M., Tang, Q., Tsai, S., Santamaria, P., Bluestone, J. A., Brillantes, A.-M. B., & Herold, K. C. (2007) · Endocrinology · doi:10.1210/en.2007-0358 · Cited by 169
Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes
Sherry, N., Kushner, J. A., Glandt, M., Kitamura, T., Brillantes, A.-M. B., & Herold, K. C. (2006) · Diabetes · doi:10.2337/db05-1034 · Cited by 152
Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice
Hulbert, C., Riseili, B., Rojas, M., & Thomas, J. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5535 · Cited by 143
Effective B Cell Depletion with Rituximab in the Treatment of Autoimmune Diseases
Kneitz, C. (2002) · Immunobiology · doi:10.1078/0171-2985-00200 · Cited by 140
Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner, T. (2006) · PubMed · Cited by 85
Hawkes, C. J., Wasmeier, C., Christie, M. R., & Hutton, J. C. (1996) · Diabetes · doi:10.2337/diab.45.9.1187 · Cited by 76
Autoantibody markers for the diagnosis and prediction of type 1 diabetes
Wasserfall, C. H., & Atkinson, M. A. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.12.002 · Cited by 75
Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner, S., Gale, E. A. M., Williams, A. J. K., Gillespie, K. M., Lawrence, K. E., Bottazzo, G. F., & Bingley, P. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.2049 · Cited by 72
SERREZE, D. V., & Silveira, P. A. (2002) · KARGER eBooks · doi:10.1159/000066863 · Cited by 55
Role of Autoantibodies in Type 1 Diabetes
Miao, D., Yu, L., & Eisenbarth, G. S. (2006) · Frontiers in bioscience · doi:10.2741/2195 · Cited by 55
B Cells in Autoimmune Diabetes
Wong, F. S., & Li, W. (2005) · The Review of Diabetic Studies · doi:10.1900/rds.2005.2.121 · Cited by 53
Self-citationTGF- signaling is required for the function of insulin-reactive T regulatory cells
Du, W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27030 · Cited by 48
Self-citationB Lymphocyte Depletion in Rheumatoid Arthritis:Targeting of CD20
Edwards, J., Leandro, M. J., & Cambridge, G. (2004) · KARGER eBooks · doi:10.1159/000082103 · Cited by 43
Peng, J., Dicker, B. L., Du, W., Tang, F., Nguyen, P., Geiger, T. L., Wong, F. S., & Li, W. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.015 · Cited by 26
Self-citationBeyan, H., Ola, T. O., David, R. Á., & LESLIE, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.011 · Cited by 20
Cited by
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
Wang, R.-X., Yu, C.-R., Dambuza, I. M., Mahdi, R. M., Dolinska, M. B., Sergeev, Y. V., Wingfield, P. T., Kim, S.-H., & Egwuagu, C. E. (2014) · Nature Medicine · doi:10.1038/nm.3554 · Cited by 733
Metadata
- Authors
- Hu, C.-Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J., & Wen, L.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3857-3867
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1997452174
- Cited by
- 426
- References
- 45
- FWCI
- 19.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.